ATLANTA, GA--(Marketwired - January 21, 2015) - Perma-Fix Environmental Services, Inc. (PESI), today announced that a consortium led by Perma-Fix Medical, a subsidiary of the company, received an ...
− NorthStar, leading the way as the sole U.S. commercial supplier of molybdenum-99 (Mo-99), continues expansion efforts for increased capacity and ongoing reliable supply for diagnostic imaging − ...
The Food and Drug Administration recently announced approval of the RadioGenix™ System, a technetium 99m (Tc-99m) generator. The RadioGenix™ System is developed by NorthStar Medical Radioisotopes, LLC ...
ATLANTA, GA--(Marketwired - May 08, 2015) - Perma-Fix Environmental Services, Inc. (PESI), today announced that Perma-Fix Medical S.A., a subsidiary of the company, has formally accepted the grant ...
− Concentrated molybdenum-98 (cMo-98) enables up to four-fold increase of critical medical radioisotope Mo-99 production in U.S. – BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, ...
Tackling supply shortages: As the supply chain for medical radioisotopes continues to struggle, researchers are developing new methods for producing technetium-99m, and exploring the potential of ...
NorthStar Medical Radioisotopes, a privately-held Wisconsin company, announced today that the FDA and the Nuclear Regulatory Commission (NRC) approved the company’s RadioGenix System for producing ...
− Collaboration enables integrating technology expertise to provide Tc-99m Generation Systems (TCM Generation Systems) that utilize non-uranium based Mo-99 produced using electron beam accelerators − ...
As a radioactive tracer, technetium-99m is used in nuclear medicine medical imaging procedures. It has a six-hour half-life and does not last long in the body or in the atmosphere. Tc-99m is primarily ...
BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its ...
Aging nuclear reactors often struggle to stay on line, a fact that’s just as true for small research reactors as it is for massive power plants. So it shouldn’t have been surprising that during 2008, ...